Compare ZVRA & KRNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZVRA | KRNY |
|---|---|---|
| Founded | 2006 | 1884 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.9M | 504.9M |
| IPO Year | 2015 | 2014 |
| Metric | ZVRA | KRNY |
|---|---|---|
| Price | $10.29 | $7.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $23.00 | $8.00 |
| AVG Volume (30 Days) | ★ 694.8K | 286.1K |
| Earning Date | 05-12-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 5.51% |
| EPS Growth | ★ 159.21 | 130.22 |
| EPS | ★ 1.35 | 0.30 |
| Revenue | ★ $106,470,000.00 | $2,580,000.00 |
| Revenue This Year | $37.27 | $3.89 |
| Revenue Next Year | $53.42 | $17.52 |
| P/E Ratio | ★ $7.26 | $26.60 |
| Revenue Growth | ★ 350.91 | 36.00 |
| 52 Week Low | $6.85 | $5.76 |
| 52 Week High | $13.16 | $8.50 |
| Indicator | ZVRA | KRNY |
|---|---|---|
| Relative Strength Index (RSI) | 63.24 | 59.02 |
| Support Level | $8.29 | $7.77 |
| Resistance Level | $11.19 | $7.95 |
| Average True Range (ATR) | 0.40 | 0.16 |
| MACD | 0.06 | 0.06 |
| Stochastic Oscillator | 98.12 | 70.05 |
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.